Leflunomid Sandoz

Leflunomide, the active ingredient in Leflunomid Sandoz, is an immunomodulator presented as an oral formulation for oral use. It is used to treat inflammatory arthritis conditions such as rheumatoid arthritis and psoriatic arthritis in adult patients.

GNH USA supplies Leflunomid Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Leflunomide is a disease‑modifying antirheumatic drug (DMARD) that targets inflammatory pathways in arthritis.

- Rheumatoid arthritis: reduces joint inflammation, pain, and slows structural damage. - Psoriatic arthritis: improves skin lesions and joint symptoms, helping maintain function.

Leflunomide may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Diarrhea: loose stools or increased bowel movements. - Nausea: feeling of sickness or urge to vomit. - Alopecia: thinning or loss of hair. - Rash: mild skin eruptions or itching. - Elevated liver enzymes: increased ALT/AST levels. - Hypertension: rise in blood pressure.

Serious or Rare Side Effects: - Severe liver injury: jaundice, hepatitis, or liver failure. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Bone marrow suppression: anemia, leukopenia, or thrombocytopenia. - Interstitial lung disease: cough, shortness of breath, and pulmonary infiltrates. - Serious infections: opportunistic or severe bacterial infections. - Teratogenic effects: fetal malformations if exposure occurs during pregnancy.

Before initiating therapy with Leflunomid Sandoz, several safety considerations should be observed.

- Pregnancy contraindication: avoid use in pregnant women and discontinue immediately if pregnancy occurs. - Liver function monitoring: assess baseline liver enzymes and repeat regularly during treatment. - Hematologic monitoring: perform complete blood counts to detect possible bone‑marrow suppression. - Blood pressure control: monitor and manage hypertension throughout therapy. - Infection risk: evaluate for active infections and avoid initiating treatment in the presence of serious infection. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture.

Leflunomide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, may raise INR. - Methotrexate: additive toxicity, especially hepatic and hematologic. - Cyclosporine: heightened risk of liver injury and hypertension.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin): possible increase in statin plasma levels, monitor for myopathy. - Live vaccines: reduced efficacy and potential for infection; avoid administration during treatment.